Cited by 183RNA Research and SplicingCancer-related molecular mechanisms researchNeuroinflammation and Neurodegeneration Mechanisms

Noncoding RNAs in neurodegeneration

Open access
Salta, Evgenia, De Strooper, Bart·2017·Nature Reviews Neuroscience

Abstract

The emerging complexity of the transcriptional landscape poses great challenges to our conventional preconceptions of how the genome regulates brain function and dysfunction. Non-protein-coding RNAs (ncRNAs) confer a high level of intricate and dynamic regulation of various molecular processes in the CNS and they have been implicated in neurodevelopment and brain ageing, as well as in synapse function and cognitive performance, in both health and disease. ncRNA-mediated processes may be involved in various aspects of the pathogenesis of neurodegenerative disorders. Understanding these events may help to develop novel diagnostic and therapeutic tools. Here, we provide an overview of the complex mechanisms that are affected by the diverse ncRNA classes that have been implicated in neurodegeneration.

Integrity signals

Registry

Crossref · 10.1038/nrn.2017.90

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Noncoding RNAs can influence the expression of other genes through multiple mechanisms to cause a wide range of disorders.

    “they can influence the expression of other genes through multiple mechanisms to cause a wide range of disorders.215–218”
  • Earlier reviews have largely focused on global miRNA expression shifts in AD brain tissue, therapeutic miRNA candidates, or body-fluid biomarker signatures, but do not present how miRNA dysfunction propagates across interacting CNS cell types.

    “Earlier reviews have largely focused on global miRNA expression shifts in AD brain tissue, therapeutic miRNA candidates, or body-fluid biomarker signatures (Li et al., 2024; Long et al., 2012; Salta and De Strooper, 2017; Samadian et al., 2021; Walgrave et al., 2021b; Wei et al., 2020; Yoon et al., 2022). Although these approaches are valuable, they do not present how miRNA dysfunction propagates”

    From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Salta and De Strooper, 2017

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Salta, E., & De Strooper, B.
Affiliations
VIB-KU Leuven Center for Brain & Disease Research (BE)
Corresponding author
Salta, Evgenia
Venue
Nature Reviews Neuroscience
Published
2017-08-17
Volume
18
Issue
10
Pages
627-640
ISSN
  • 1471-003X (ISSN-L)
  • 1471-0048
OpenAlex
W2745561846
Cited by
183
References
21
Citations by year
2026: 11 · 2025: 18 · 2024: 23 · 2023: 19 · 2022: 22 · 2021: 19 · 2020: 37 · 2019: 18 · 2018: 15 · 2017: 1
FWCI
1.82
Type
journal article
Language
en
Open access
Locations
  • Nature reviews. Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Lirias (KU Leuven) (submittedVersion)
Funders
  • Alzheimer's Association
  • Fonds Wetenschappelijk Onderzoek
  • Vlaamse regering
  • Medical Research Council (MC_PC_17116)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
non-coding RNA, neurodegenerative diseases, transcriptional regulation, brain aging, brain development, synaptic function, cognitive performance, pathogenesis
MeSH terms
Animals, Brain, Gene Expression Regulation, Humans, Models, Genetic, Nerve Tissue Proteins, Neurodegenerative Diseases, RNA, Untranslated

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review